MDM4 and ovarian cancer: In order to estimate the potential impact of MDM4 SNP34091 status on ovarian cancer risk, we compared the frequency of the MDM4 SNP34091 genotypes among ovarian cancer patients (n = 1385) to healthy female controls (n = 1870).